Literature DB >> 21501537

Pregnancy-associated breast cancer: a review for the obstetrical care provider.

Lionel A Buré1, Laurent Azoulay, Alice Benjamin, Haim A Abenhaim.   

Abstract

Breast cancer is uncommon in pregnancy, but obstetrical care providers should nevertheless be familiar with the presenting signs and symptoms. The incidence of breast cancer in pregnancy and the postpartum period ranges from 2.3 to 40 cases per 100 000 women. Over 90% of patients with breast cancer in pregnancy or during lactation present with a palpable mass, and most often (84%) these are self-reported by patients. Less frequently, breast cancer will present as breast erythema, breast swelling, bloody nipple discharge, or local or distant metastasis. The histology of tumours appears to be similar in women who are pregnant or recently delivered and in age-matched women who are not pregnant. However, the stage of disease at diagnosis is more advanced in women who are pregnant or recently delivered and consequently incurs a worst prognosis, likely due to a delay in diagnosis. Although the majority of palpable breast masses are benign, breast examinations should routinely be performed in pregnant women, and identified masses should be promptly evaluated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501537     DOI: 10.1016/s1701-2163(16)34850-2

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  3 in total

1.  Imaging in pregnancy-associated breast cancer: a case report.

Authors:  Audrius Untanas; Indrė Grigaitė; Rūta Briedienė
Journal:  Acta Med Litu       Date:  2019

2.  A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria.

Authors:  Stella O Odedina; IkeOluwapo O Ajayi; Adenike Adeniji-Sofoluwe; Imran O Morhason-Bello; Dezheng Huo; Olufunmilayo I Olopade; Oladosu A Ojengbede
Journal:  BMC Womens Health       Date:  2018-09-19       Impact factor: 2.809

Review 3.  The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer.

Authors:  María Inés Diaz Bessone; María José Gattas; Tomás Laporte; Max Tanaka; Marina Simian
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-08       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.